Zepbound shortage update: FDA issues ‘limited availability’ warning. When might it end?
4
According to the FDA, affected doses of Eli Lilly’s popular weight loss drug are expected to see limited availability until the end of April.
In response to a surge in demand, Zepbound, the weight loss drug manufactured by Eli Lilly, is facing a shortage of certain doses in the United States, as highlighted in a recent warning issued by the Food and Drug Administration (FDA).